Literature DB >> 10331856

Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation.

K Ando1, S Koike, C Ohira, Y J Chen, K Nojima, S Ando, T Ohbuchi, N Kobayashi, W Shimizu, M Urano.   

Abstract

PURPOSE: Reoxygenation of a murine tumour after irradiation with carbon ions was investigated and compared to that after gamma-rays.
MATERIALS AND METHODS: NFSa fibrosarcoma cells were transplanted into the right hind legs of syngeneic C3H male mice. Conditioning irradiation with either 290 MeV/u carbon ions or 137-Cs gamma-rays was delivered to the tumours at 8 mm diameter. At given times after irradiation the leg tumours, either clamped or not, received test doses of photons. Differences in tumour growth delay between the clamped and non-clamped tumours were interpreted in terms of reoxygenation. A lung-colony assay was used to obtain cell-survival curves.
RESULTS: The oxygen enhancement ratio in the NFSa tumour for 74 keV microm(-1) carbon ions was 1.6 while that for gamma-rays was 3.4. The NFSa tumours reoxygenated 4 days after 30 Gy of gamma-ray irradiation, but reoxygenated as early as 1 day after 16 Gy of carbon ions. Reoxygenation after gamma-rays shortened to 1 day when the tumours were initially clamped for the conditioning irradiation.
CONCLUSIONS: The fraction of surviving oxic cells in the NFSa tumours is larger after irradiation with carbon ions than with gamma-rays, resulting in accelerated reoxygenation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331856     DOI: 10.1080/095530099140438

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  16 in total

Review 1.  Charged-particle therapy for hepatocellular carcinoma.

Authors:  Heath D Skinner; Theodore S Hong; Sunil Krishnan
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.

Authors:  Mitsuhiko Hasebe; Kyosan Yoshikawa; Seiya Ohashi; Sachiko Toubaru; Koji Kawaguchi; Junichi Sato; Junetsu Mizoe; Hirohiko Tsujii
Journal:  Mol Imaging Biol       Date:  2010-10       Impact factor: 3.488

3.  Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Hideko Nagasawa; Kenji Nagata; Minoru Suzuki; Yoshihiro Uto; Hitoshi Hori; Yuko Kinashi; Koji Ono
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-22       Impact factor: 4.553

4.  Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential.

Authors:  S Masunaga; Y Liu; H Tanaka; Y Sakurai; M Suzuki; N Kondo; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2011-05-17       Impact factor: 3.039

5.  Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.

Authors:  Shin-Ichiro Masunaga; Hideko Nagasawa; Keiko Gotoh; Yoshinori Sakurai; Yoshihiro Uto; Hitoshi Hori; Kenji Nagata; Minoru Suzuki; Akira Maruhashi; Yuko Kinashi; Koji Ono
Journal:  Radiat Med       Date:  2006-02

Review 6.  Recent advancements in multimodality treatment of gliomas.

Authors:  Mersiha Hadziahmetovic; Katsuyuki Shirai; Arnab Chakravarti
Journal:  Future Oncol       Date:  2011-10       Impact factor: 3.404

7.  [11C]Gefitinib ([11c]Iressa): radiosynthesis, in vitro uptake, and in vivo imaging of intact murine fibrosarcoma.

Authors:  Ming-Rong Zhang; Katsushi Kumata; Akiko Hatori; Nobuhiko Takai; Jun Toyohara; Tomoteru Yamasaki; Kazuhiko Yanamoto; Joji Yui; Kazunori Kawamura; Sachiko Koike; Koichi Ando; Kazutoshi Suzuki
Journal:  Mol Imaging Biol       Date:  2009-09-26       Impact factor: 3.488

8.  Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.

Authors:  Huagang Hou; Sriram P Mupparaju; Jean P Lariviere; Sassan Hodge; Jiang Gui; Harold M Swartz; Nadeem Khan
Journal:  Radiat Res       Date:  2013-02-07       Impact factor: 2.841

9.  Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.

Authors:  Huagang Hou; Jean P Lariviere; Eugene Demidenko; David Gladstone; Harold Swartz; Nadeem Khan
Journal:  Radiother Oncol       Date:  2008-11-14       Impact factor: 6.280

10.  Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Yoshitaka Matsumoto; Ryoichi Hirayama; Genro Kashino; Hiroki Tanaka; Minoru Suzuki; Yuko Kinashi; Yong Liu; Koichi Ando; Koji Ono
Journal:  Clin Exp Metastasis       Date:  2009-05-23       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.